Proteomics

Proteomics focuses on the large-scale study of the key functional molecules of life: the proteins. Unlike the relatively static genome, the proteome is dynamic and reflects the real-time physiological state of a cell or tissue. Understanding protein expression, modification, and interaction patterns provides deep insights into biological processes and disease mechanisms.

Proteomics services play a crucial role in biomarker discovery, drug-target identification, and mechanism-of-action studies. By comparing proteomic profiles between healthy and diseased states or before and after treatment, we help identify molecular signatures relevant for early diagnosis, patient stratification, and therapeutic response prediction.

The application areas of our proteomics platform span oncology, neurology, immunology, infectious diseases, and metabolic research.

Whether for translational research, preclinical studies, or pharmaceutical development, our workflows are optimized to deliver high-quality, biologically meaningful results.

At CeGaT, we offer comprehensive proteomics solutions that enable detailed characterization of protein abundance and signaling pathways. With a team of experienced scientists and state-of-the-art analytical infrastructure, CeGaT ensures data reliability and scientific excellence. Our laboratories operate under accredited quality standards (including DIN EN ISO 17025 and equivalent frameworks) to guarantee reproducibility and regulatory compliance.

By transforming complex proteomic data into actionable biological insights, CeGaT empowers researchers and pharmaceutical partners to advance precision medicine and accelerate the development of novel therapeutic strategies.